POZEN Inc (NASDAQ:POZN) to Present at Jefferies & Co. Annual Healthcare Conference June 24
Atlanta, GA 6/06/2008 02:30 PM GMT (TransWorldNews)
POZEN, Inc (NASDAQ:POZN) will speak at the Jeffereies & Co Annual Healthcare Conference on Tuesday, June 24 at 8:00 am ET in New York, NY. Interested parties may listen to the presentation via webcast at phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=121701&eventID=1863098.
POZEN Inc. (POZEN) is a pharmaceutical company focused on developing products, which can provide improved efficacy, safety or patient convenience in the treatment of acute and chronic pain, and pain related conditions.
The Company has developed Treximet (formerly known as Trexima) in collaboration with GlaxoSmithKline (GSK). Treximet is the proposed brand name for the product candidate combining sumatriptan 85 milligram, as the succinate salt, formulated with RT Technology and naproxen sodium 500 milligram in a single tablet designed for the acute treatment of migraine.
The United States Food and Drug Administration (FDA) has notified POZEN that it has tentatively accepted the trade name Treximet, subject to final approval of the new drug application (NDA) for the product. Treximet incorporates the Company’s MT 400 technology, which refers to its combinations of a triptan (5-HT1B/1D agonist) and a non-steroidal, anti-inflammatory drug (NSAID).
Find more Conference Calls or post your own events on YourFindit Events at:
http://events.yourfindit.com/Events_List.aspx?catid=12
Join the brand-new business networking community site, YourFindit, and create your profile.
befound@finditt.com
events.finditt.com
Email Article to a friend
|
View Profile
Visit Blogs
|
NEWS ALERTS
Receive alerts for
Finditt Business
to your inbox.
Sign up for TransWorldNews Alerts
TransWorldNews, Inc. and its affiliate sites disclaim all liability for information and content provided by clients and appearing within their news and press releases.
